Literature DB >> 11710113

Conjugation of von Willebrand factor-binding domain of platelet glycoprotein Ib alpha to size-controlled albumin microspheres.

S Takeoka1, Y Teramura, H Ohkawa, Y Ikeda, E Tsuchida.   

Abstract

Albumin microspheres (AMS), of which the average diameter is 240 +/- 10 nm, were prepared by pH control and heat treatment. Cytochrome c and rGPIb alpha; a water-soluble fragment of the alpha chain of a recombinant platelet glycoprotein (GP)Ib containing a von Willebrand factor (vWf)-binding site were selected as a receptor protein. Cytochrome c was used as a probe protein for monitoring. Onto the surface of the AMS and those proteins, N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP) was reacted through the amide linkage to obtain PD-AMS, PD-cytochrome c, and PD-rGPIb alpha, respectively. The latter two were further reduced to SH-cytochrome c and SH-rGPIb alpha by dithiothreitol and conjugated with PD-AMS by a thiol-disulfide exchange reaction. The resulting AMS contain cytochrome c or rGPIb alpha of about 25,000 or 2500 molecules, respectively. The addition of ristocetin to the rGPIb alpha-AMS in the presence of vWf caused specific aggregation. Furthermore, the rGPIb alpha-AMS enhanced the ristocetin induced platelet aggregation in a low platelet concentration (4.0 x 10(7)/mL).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11710113     DOI: 10.1021/bm0055293

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  3 in total

1.  New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.

Authors:  Yosuke Okamura; Makoto Handa; Hidenori Suzuki; Yasuo Ikeda; Shinji Takeoka
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

2.  EphA2 targeted intratumoral therapy for non-small cell lung cancer using albumin mesospheres.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Fredric Kaye; Brij M Moudgil; Najmunnisa Nasreen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 3.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.